Literature DB >> 7374882

Mechanism by which uptake inhibitors antagonize p-chloroamphetamine-induced depletion of brain serotonin.

R W Fuller.   

Abstract

The mechanism by which uptake inhibitors antagonize p-chloroamphetamine (PCA)-induced depletion of brain serotonin has been suggested to involve: (1) blockade of PCA uptake into the serotonin neuron by means of the membrane carrier, or (2) blockade of the efflux of released serotonin from the neuron, this efflux also requiring the membrane carrier. According to either mechanism, antagonism of serotonin depletion by PCA would provide a valid index of inhibition of the amine uptake system on serotonin neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7374882     DOI: 10.1007/bf00964612

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties.

Authors:  J B Lassen; R F Squires; J A Christensen; L Molander
Journal:  Psychopharmacologia       Date:  1975-04-30

2.  Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5-hydroxytrptamine by L-dopa.

Authors:  R W Fuller; K W Perry
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

3.  Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain.

Authors:  R W Fuller; K W Perry
Journal:  Neuropharmacology       Date:  1977 Jul-Aug       Impact factor: 5.250

4.  1-[2-Amino-1-[1-(naphthyloxy)methyl] ethyl] piperidine hydrochloride: specific inhibition of brain serotonin uptake and related activities.

Authors:  T A Pugsley; W Lippmann
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-08

5.  Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice.

Authors:  R W Fuller; K W Perry; H D Snoddy; B B Molloy
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

6.  Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine.

Authors:  G Le Fur; N Mitrani; A Uzan
Journal:  Biochem Pharmacol       Date:  1977-03-15       Impact factor: 5.858

7.  Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine.

Authors:  R W Fuller; H D Snoddy; K W Perry; F P Bymaster; D T Wong
Journal:  Biochem Pharmacol       Date:  1978-01-15       Impact factor: 5.858

8.  P-Chloramphetamine: Selective neurotoxic action in brain.

Authors:  J A Harvey; S E McMaster; L M Yunger
Journal:  Science       Date:  1975-03-07       Impact factor: 47.728

9.  Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex.

Authors:  S B Ross; D Kelder
Journal:  Acta Physiol Scand       Date:  1977-01

10.  Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems.

Authors:  M F Sugrue; G Shaw; K G Charlton
Journal:  Eur J Pharmacol       Date:  1977-04-21       Impact factor: 4.432

View more
  7 in total

1.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 2.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 3.  Effects of p-chloroamphetamine on brain serotonin neurons.

Authors:  R W Fuller
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

4.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Authors:  G Rudnick; S C Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

5.  Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine.

Authors:  J J Balsara; T R Bapat; N V Nandal; V P Gada; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.

Authors:  A L Ask; I Fagervall; R B Huang; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

7.  Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Authors:  Lucina E Lizarraga; Andy V Phan; Aram B Cholanians; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-03-04       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.